Paul Peter Tak - Nov 21, 2024 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Charles Schoch as Attorney-in-Fact for Paul Peter Tak
Stock symbol
CADL
Transactions as of
Nov 21, 2024
Transactions value $
$19,995
Form type
4
Date filed
11/21/2024, 03:07 PM
Previous filing
Jul 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Options Exercise $20K +12.9K +3.9% $1.55 344K Nov 21, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Options Exercise $0 -12.9K -0.73% $0.00 1.76M Nov 21, 2024 Common Stock 12.9K $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option vested and became exercisable on October 10, 2020, with another 25% vesting on October 10, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.